{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:25:22Z","timestamp":1778081122166,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jaad.2016.04.029","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T03:16:26Z","timestamp":1478920586000},"page":"1278-1280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rethinking screening for thyroid autoimmunity in vitiligo"],"prefix":"10.1016","volume":"75","author":[{"given":"Michael","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin Huiras","family":"Amerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2016.04.029_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2016.04.029_bib2","doi-asserted-by":"crossref","first-page":"E1335","DOI":"10.1210\/jc.2015-2126","article-title":"A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies","volume":"100","author":"Schunter","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2016.04.029_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2003.02089.x","article-title":"Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?","volume":"131","author":"Zettinig","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2016.04.029_bib4","series-title":"Andrews' diseases of the skin: clinical dermatology","first-page":"855","article-title":"Disturbances of pigmentation","author":"James","year":"2011"},{"key":"10.1016\/j.jaad.2016.04.029_bib5","series-title":"Dermatology","article-title":"Vitiligo and other disorders of hypopigmentation","author":"Ortonne","year":"2012"},{"key":"10.1016\/j.jaad.2016.04.029_bib6","series-title":"Fitzpatrick's color atlas and synopsis of clinical dermatology","first-page":"288","article-title":"Pigmentary disorders","author":"Wolff","year":"2013"},{"issue":"1","key":"10.1016\/j.jaad.2016.04.029_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum Consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.04.029_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2016.04.029_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.029_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaad.2016.04.029_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the\u00a0American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.jaad.2016.04.029_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2016.04.029_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.jaad.2016.04.029_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/jc.2009-1977","article-title":"Thyrotropin and thyroid antibodies as predictors of\u00a0hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques","volume":"95","author":"Walsh","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2016.04.029_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2133.2011.10717.x","article-title":"Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo","volume":"166","author":"Kroon","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.029_bib16","unstructured":"Endocrine Society. Choosing wisely: five things physicians and\u00a0patients should question. Available from: URL: http:\/\/www.choosingwisely.org\/societies\/endocrine-society\/. Accessed December 2, 2016."},{"issue":"Suppl","key":"10.1016\/j.jaad.2016.04.029_bib17","first-page":"S17","article-title":"Initial evaluation and diabetes\u00a0management planning","volume":"38","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:40:46Z","timestamp":1759272046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221630130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S019096221630130X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking screening for thyroid autoimmunity in vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}